Article
Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium.
Proceedings of the National Academy of Sciences of the United States of America - 9 Apr 2013
Ryan Zachary C, Ketha Hemamalini, McNulty Melissa S, McGee-Lawrence Meghan, Craig Theodore A, Grande Joseph P, Westendorf Jennifer J, Singh Ravinder J, Kumar Rajiv
Abstract excerpt
Inactivating mutations of the SOST (sclerostin) gene are associated with overgrowth and sclerosis of the skeleton. To determine mechanisms by which increased amounts of calcium and phosphorus are accreted to enable enhanced bone mineralization in the absence of sclerostin, we measured concentrations of calciotropic and phosphaturic hormones, and urine and serum calcium and inorganic phosphorus in mice in which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
